Allogene Therapeutics, Inc. (ALLO) vs YD Bio Limited (YDES)

Allogene Therapeutics, Inc. ALLO 1.31 −2.24%
YD Bio Limited YDES 5.92 −12.17%

Allogene Therapeutics, Inc. and YD Bio Limited are both Biotechnology companies. Allogene Therapeutics, Inc. and YD Bio Limited are of similar size ($477.5M and $463.0M).

Metric	ALLO	YDES	Biotechnology median
P/E	n/m	—	8.50
P/S	91.58	—	9.71
P/B	0.99	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	n/m	—	0.64
EV/Sales	20.89	—	9.21
Earnings yield	(51.15%)	—	(33.15%)
Free cash flow yield	(23.81%)	—	(25.50%)

Metric	ALLO	YDES	Biotechnology median
Gross margin	100.00%	—	65.16%
Operating margin	(3,832.45%)	—	0.00%
Net margin	(3,517.41%)	—	0.00%
Free cash flow margin	(2,180.62%)	—	0.00%
Return on equity	(42.39%)	—	(56.36%)
Return on assets	(32.43%)	—	(48.04%)
Return on invested capital	(108.81%)	—	0.00%

Metric	ALLO	YDES	Biotechnology median
Revenue growth (TTM)	7,613.11%	—	6.02%
EPS growth (last fiscal year)	34.09%	—	30.26%
Revenue growth, 5-year CAGR	—	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ALLO	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	10.72	—	4.72
Net debt to EBITDA	1.24	—	0.96

Metric	ALLO	YDES	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	ALLO	YDES	Biotechnology median
Market cap	462.96m	477.48m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack